A Global Pharmaceutical Business Builds Its Research and Talent Pipeline
A Storied American Healthcare Benefits Company Looks to Extend its Reach
A Multichannel Retailer Looks to Build Its Business Holistically
Health, Pharma and Leadership. Quality executives used to be the in-house police; internal affairs officers investigating production errors and mishaps and reporting them up the chain of command.
Fundamental changes in the marketplace for medicines, as well as the rapid and continuing evolution of technology are bringing new challenges and opportunities for life sciences companies and their contribution to healthcare systems.
With Sarbanes-Oxley increasing the responsibilities shouldered by today’s directors, do some individuals have a seat on too many US boards, asks The Boston Globe?
Healthcare has been in a state of steady, sometimes grudging, transformation for years. What’s different today is the dramatically accelerated pace of change that has been brought on by a combination of regulatory pressures, high costs, consumer empowerment, and revolutionary technological and medical innovation.
To win in Consumer Health, neither core strength is by itself sufficient. In order to succeed, companies must marry the traditional strengths of both Pharma and Consumer and even go beyond. What sounds so simple is actually a long journey: a strategic imperative achievable only by talent that transcends what has traditionally been required to win in either sector.
The generics industry has entered a phase of radical transformation. Rapid globalization, continuing consolidation, and increasing business complexity have turned formerly regional players into global operations.
You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.
Continue to the website